(R) -3-Amino-1-Butanol CAS 61477-40-5 Purity > 99.0% (GC) Factaraidh Eadar-mheadhanach Dolutegravir
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (R)-3-Amino-1-Butanol (CAS: 61477-40-5) with high quality, commercial production. It's an intermediate of Dolutegravir (CAS: 1051375-16-6). We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available, strong after-sale service. Please contact: alvin@ruifuchem.com
Ainm Ceimigeach | (R) -3-Amino-1-Butanol |
Co-fhaclan | (R) -3-Aminobutan-1-ol;(3R) -3-Amino-1-Butanol |
Àireamh CAS | 61477-40-5 |
Àireamh CAT | RF-CC317 |
Inbhe Stoc | Ann an stoc, ìre toraidh suas gu tonna |
Foirmle Molecular | C4H11NO |
Cuideam Molecular | 89.14 |
Iom-tharraing sònraichte (20/20) | 0.95 |
Clàr-innse Refractive | 1.45 |
Cuairteachadh sònraichte [α]20/D | -12.0 ° ~ -10.0 ° (C = 1, EtOH) |
Brand | Ceimigeach Ruifu |
Coltas | Gun dath gu leaghan buidhe aotrom | Liath Buidhe Aotrom |
Aithneachadh le IR | A’ gèilleadh ri Spectrum of the Standard | A 'gèilleadh |
Aithneachadh le GC | A 'gèilleadh ri Àm Glèidhidh na h-Inbhe | A 'gèilleadh |
Purity le GC (A%) | > 99.0% | 99.8% |
Stuthan Co-cheangailte | Singilte Impurity sam bith: <0.5% | 0.09% |
Neo-dhìomhaireachd iomlan: <1.0% | 0.28% | |
S-Isomer (le HPLC A%) | <0.10% | 0.02% |
Susbaint uisge le KF | <0.50% | 0.10% |
Assay le GC (w/w%) | > 99.0% | 99.3% |
Pacaid: Botal fluorinated, 25kg / Drum, no a rèir riatanas luchd-ceannach
Suidheachadh stòraidh:Bùth ann an soithichean dùinte ann an àite fionnar is tioram;Dìon bho sholas is taiseachd
(R) -3-Amino-1-Butanol (CAS: 61477-40-5) a chleachdadh mar eadar-mheadhanach ann a bhith ag ullachadh todhar le gnìomhachd casg HIV integrase.(R) -3-Amino-1-Butanol na eadar-mheadhanach de Dolutegravir (CAS: 1051375-16-6).B’ e seòrsa ùr de dhroga anti-ADIS a bh’ ann an Dolutegravir (Tivicay) a leasaich am fuamhaire cungaidh Breatannach GlaxoSmithKline (GSK) còmhla ri Companaidh Cungaidh-leigheis Iapanach Shionogi (Shionogi).Anns an Lùnastal 2013, dh’ aontaich FDA na SA dolutegravir (cuideachd air ainmeachadh mar S / GSK1349572) airson làimhseachadh galair HIV-1 ann an inbhich agus clann aois 12 bliadhna agus nas sine an co-bhonn ri drogaichean antiretroviral eile.